SCHEMBL5776632

SCHEMBL5776632

Cc1nc(C2CCNCC2)c2nc(C)c(Cc3ccccc3)c-2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRB2 P47870 2/20 0.38
KHK P50053 1/20 0.36
CCR2 P41597 1/20 0.36
HRH1 P35367 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GBA1 P04062 1/20 0.35
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC18A3 Q16572 1/20 0.35
SIGMAR1 Q99720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777830 0.78 SLC6A2 (0.43) GABRA1GABRG2GABRB3KHKHRH1
Hydrochloric Acid SCHEMBL5775248 0.75 KDM4E (0.44) GABRA1GABRB2SLC18A3SIGMAR1
SCHEMBL5774480 0.75 KDM4E (0.44) GABRA1GABRB2SLC18A3SIGMAR1
Hydrochloric Acid SCHEMBL5807137 0.74 KDM4E (0.43) GABRA1GABRB2SLC18A3SIGMAR1
Hydrochloric Acid SCHEMBL5776951 0.74 KDM4E (0.43) GABRA1GABRB2SLC18A3SIGMAR1
Hydrochloric Acid SCHEMBL5773701 0.74 KDM4E (0.47) GABRA1GABRG2GABRB3GABRB2SLC18A3
SCHEMBL5776541 0.71 MAPK14 (0.45)
SCHEMBL3949876 0.68 GABRA1 (0.52) GABRA1GABRG2GABRB3GABRB2HRH1
SCHEMBL5775115 0.68 USP7 (0.41) GABRA1GABRB2
SCHEMBL5774851 0.68 MAPK14 (0.48) GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed